Publications

BibTex format

@article{Rodriguez:2010,
author = {Rodriguez, B and Burrage, K and Gavaghan, D and Grau, V and Kohl, P and Noble, D},
journal = {Clin Pharmacol Ther},
pages = {130--134},
title = {The Systems Biology Approach to Drug Development: Application to Toxicity Assessment of Cardiac Drugs},
volume = {88},
year = {2010}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Side effects account for most of the instances of failure of candidate drugs at late stages of development. These development failures contribute to the exorbitant cost of bringing new compounds to market: a single withdrawal can represent a loss of more than $1 billion. Many unwanted actions of drugs affect the heart, resulting in potentially proarrhythmic alteration of ion channel function. Because these can be fatal, potential electrophysiological cardiotoxicity is among the most stringent exclusion criteria in the licensing process.
AU  - Rodriguez,B
AU  - Burrage,K
AU  - Gavaghan,D
AU  - Grau,V
AU  - Kohl,P
AU  - Noble,D
EP  - 134
PY  - 2010///
SN  - 0009-9236
SP  - 130
TI  - The Systems Biology Approach to Drug Development: Application to Toxicity Assessment of Cardiac Drugs
T2  - Clin Pharmacol Ther
VL  - 88
ER  -

Download

ProfessorPeterKohl

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)